Integrated Vaccine and IoT-Blockchain-AI System for Necrotic Enteritis Prevention in Poultry
Legal Citation
Summary of the Inventive Concept
A synergistic combination of a plant-based vaccine containing a PlcC-NetB fusion protein with IoT, blockchain, AI, and nanocarrier technologies to prevent necrotic enteritis in poultry, enabling real-time monitoring, secure tracking, and optimized vaccination processes.
Background and Problem Solved
Necrotic enteritis is a significant disease affecting poultry worldwide, causing substantial economic losses. The original patent disclosed a vaccine for prevention of necrotic enteritis in poultry, but it lacked the integration of advanced technologies to enhance its effectiveness. The new inventive concept addresses this limitation by combining the vaccine with IoT, blockchain, AI, and nanocarrier technologies to provide a comprehensive solution for necrotic enteritis prevention.
Detailed Description of the Inventive Concept
The integrated system consists of a plant-based vaccine containing a PlcC-NetB fusion protein, which is administered to poultry to prevent necrotic enteritis. The vaccine is combined with an IoT-enabled monitoring device that tracks poultry health and detects early signs of infection. The vaccination process is secured and tracked using blockchain technology, ensuring transparency and accountability. An AI-powered diagnostic tool is used to identify infected poultry and predict the risk of disease outbreaks. The vaccine is delivered using a nanocarrier system, which targets the gut of the poultry, enhancing its efficacy.
Novelty and Inventive Step
The new claims introduce a synergistic combination of advanced technologies, including IoT, blockchain, AI, and nanocarrier systems, which are not present in the original patent. The integration of these technologies with the vaccine provides a novel and non-obvious solution for necrotic enteritis prevention in poultry.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of different types of vaccines, such as mRNA-based vaccines, or the integration of other advanced technologies, such as robotics or machine learning algorithms, to enhance the system's effectiveness. Variations of the system may be designed for use in different poultry production settings, such as large-scale industrial farms or small-scale backyard farms.
Potential Commercial Applications and Market
The integrated vaccine and IoT-blockchain-AI system has significant commercial potential in the poultry industry, which is a multi-billion-dollar market. The system can be marketed to poultry producers, veterinarians, and animal health companies, offering a comprehensive solution for necrotic enteritis prevention and enhancing animal welfare.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/08 |
| A | A61 | A61P31/04 |
| C | C12 | C12N15/74 |
| C | C12 | C12N15/8258 |
| A | A61 | A61K2039/552 |
| A | A61 | A61K2039/55577 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Veterinary biotechnology, specifically vaccine development for poultry diseases, involving molecular biology, protein engineering, and infectious disease prevention
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in veterinary science or molecular biology, experienced in protein fusion techniques, vaccine design, and understanding of bacterial pathogenesis in poultry
Obviousness Rationale
A PHOSITA would recognize that integrating advanced monitoring and delivery technologies with the existing PlcC-NetB fusion vaccine represents a predictable extension of known vaccine development strategies. The combination of IoT, blockchain, and AI technologies with established vaccine platforms is a logical progression in precision veterinary medicine. The technical elements disclosed in the PTD represent incremental improvements that would be obvious to a skilled practitioner seeking to enhance vaccine efficacy and tracking.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,613 |
|---|---|
| Title | Vaccine for prevention of necrotic enteritis in poultry |
| Assignee(s) | Arizona Board of Regents on Behalf of Arizona State University |